| BELLEVUE FUNDS (LUX) - BELLEVUE MEDTECH & SERVICES I EUR | SALUD | -8,37% | 10,22% | 26,49% | 153,47% |
| NEUBERGER BERMAN US LONG SHORT EQUITY USD I (PF) DIS | GESTIÓN ALTERNATIVA | -5,42% | 11,35% | 26,49% | 49,35% |
| DNCA INVEST - ALPHA BONDS B EUR | ALTERNATIVOS. VOLAT.BAJA | 4,86% | 14,52% | 26,48% | · |
| PRIVILEDGE - WILLIAM BLAIR GLOBAL LEADERS (EUR) P CAP | RVI GLOBAL | -3,28% | 25,88% | 26,48% | 115,25% |
| ALGER SICAV - ALGER DYNAMIC OPPORTUNITIES FUND A USD | GESTIÓN ALTERNATIVA | -7,35% | 18,39% | 26,47% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | BIOTECNOLOGÍA | 39,94% | 66,29% | 26,47% | 61,02% |
| GOLDMAN SACHS ABSOLUTE RETURN TRACKER PORTFOLIO OTHER CURRENCY H SGD CAP | RETORNO ABSOLUTO | -2,46% | 10,90% | 26,46% | · |
| POLEN CAPITAL FOCUS U.S. GROWTH FUND EUR RETAIL CAP | RVI USA CRECIMIENTO | -10,67% | 34,89% | 26,45% | · |
| SCHRODER ISF ASIAN CONVERTIBLE BOND A1 ACC EUR (HEDGED) | RFI CONVERTIBLES - OTROS | 29,74% | 46,73% | 26,45% | 42,26% |
| ABRDN SICAV I-JAPANESE SUSTAINABLE EQUITY FUND I ACC JPY | RVI JAPÓN | 17,98% | 44,61% | 26,44% | 76,42% |
